Chinese Herbal Tea Mentha Haplocalyx Natural Herbs Mint Leaves Peppermint Granules Tea

Name: Chinese Herbal Tea Mentha Haplocalyx Natural Herbs Mint Leaves Peppermint Granules Tea
Brand: Xinshao Nanmo Biotechnology Co., Ltd.
SKU: 2093826175

Hunan, ChinaXinshao Nanmo Biotechnology Co., Ltd.

US$7.75

50-99 kg

US$7.07

100+ kg

Sample price:US$7.80/kg.Request sample

Product profile

Customization

Available

Style

Loose Tea

Packaging

Box

Model NO.

Mint Granules Tea

Other Name

Mint Leaves Tea

Chinese Name

Bo He

Samples

Free Sample Available

Color

Dark Green

Form

Dried Leaves

Grade

Tea Grade

Type

Mint Tea

Specialty

Health Tea

Specification

Food grade

Trademark

nanmo

Origin

Hunan

Production Capacity

10000

Company profile

High Repeat Buyers ChoiceManagement CertificationStandardized quality controlMinor Customization

Xinshao Nanmo Biotechnology Co., Ltd.

Hunan, China

Business Type: Manufacturer/FactoryExport Year: 2018-08-08Nearest Port: Shenzhen, Guangzhou, ChangshaAverage Response Time: ≤7.70hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA

AI-Powered supplier vetting

SummaryThe supplier operates in agriculture, food, health, and medicine, offering plant extracts, dried herbs, herbal tea, spices, powders, and related products. It reports an organic cultivation base exceeding 2,300 acres, a 12,000-square-meter factory, four automatic production lines, and annual output of 4,000 tons. Export activity is established, with 31%–40% of sales from exports, five years of export experience, self-operated import/export rights, and acceptance of FOB, CIF, CFR, and EXW terms. However, evidence shows limited customization and innovation, no ODM, 3D design, SDK, overseas warehouse, overseas agent, branch, showroom, or offline trade-show capability. Quality assurance is explicitly absent, while complaint handling lacks written records. Financial credibility cannot be assessed because the provided financial figures are excluded from analysis and the remaining evidence is insufficient.

Supplier typeThe supplier is positioned as an agriculture, food, health, and medicine business. Its stated scope includes edible mushroom strains, crop-seed import and export, food internet sales, plant extracts, dried herbs, herbal tea, spices, powders, sugar substitutes, and health-care products, subject to required approvals where applicable.

After-Sales capabilityThe supplier has in-stock service capacity and accepts several international quotation terms, but it has no overseas warehouse, overseas showroom, overseas agents or branches, and serves zero stated overseas countries. It has a complaint-handling procedure but no written records, limiting evidence of effective after-sales execution.

R&D capabilityInnovation evidence is weak: the supplier reports no new products in the past year, no ODM service, no SDK, and no 3D software design capability. It has two R&D engineers and provides only minor customization, which does not demonstrate strong innovation capacity.

Production capacityThe supplier reports a cultivation base exceeding 2,300 acres, a 12,000-square-meter factory, four automatic production lines, and annual output of 4,000 tons. It also states that it has in-stock capacity, but no valid manufacturing-capacity contract exists with its related subcontractor, creating a documented supply-chain control limitation.

Customization capabilityCustomization is limited to minor customization. The supplier does not provide 3D software design services or ODM services, and its R&D product-information capability is marked absent for the past year.